OCRA’s Schreiber Research Grants Program supports postdoctoral fellows, early career independent investigators, and teams of experienced investigators.
OCRA has invested $122 million in ovarian cancer research, and has awarded over 390 grants to top scientists at more than 90 leading medical centers. We invest our dollars wisely, supporting the best ovarian cancer research in the nation. With an annual grantmaking budget of more than $7 million, OCRA is the world’s largest charity funding ovarian cancer research in the United States and around the globe.
OCRA’s Schreiber Research Grants Program is named after Ann and Sol Schreiber, founders of Ovarian Cancer Research Alliance.
If you would like to join our grant opportunities mailing list so you will be informed about future grant announcements, please send an email to firstname.lastname@example.org.
Launched in 2004, this grant provides funds for large ovarian cancer research projects that involve several investigators within one institution or collaborations between groups in multiple institutions. Support of $300,000 annually for three years, for a total of $900,000, will be awarded to the institution(s) in which the recipients will conduct the research.View Collaborative Research Development Grant recipients
Launched in 2022, the purpose of this grantmaking program is to provide funds for ovarian cancer and/or related gynecologic cancers research projects using AI or machine learning that may involve several investigators within one institution or collaborations between groups in multiple institutions. OCRA is partnering with Microsoft AI for Health, a philanthropic program at Microsoft, investigators will have access to support from Microsoft in the form of Azure computing credits, and in-kind data science support. Support of $300,000 annually for three years, for a total of $900,000, will be awarded to the institution(s) in which the recipients will conduct the research in addition to the in-kind support from Microsoft.View Collaborative Research Development Grant – Microsoft AI for Health recipients
(Formerly Liz Tilberis Early Career Award) Launched in December 2000, the Early Career Investigator Grant is for junior faculty (Assistant Professor level) with a strong commitment to an investigative career in ovarian cancer research. Each grantee will receive a three-year grant of $150,000 per year, for a total of $450,000.View Early Career Investigator Grant recipients
(Formerly Ann and Sol Schreiber Mentored Investigator Award) The Mentored Investigator Grant provides funding for trainees (post-doctoral fellows or clinical fellows) who are working under the supervision of a mentor who is a recognized leader in the field of ovarian cancer research. Applicants must have an MD or a PhD degree. The grant provides a total of $75,000 to be used over one or two years, and will encourage the recipient’s research career in the field of ovarian cancer.View Mentored Investigator Grant recipients
Launched in 2024, the Health Equity Research Grant (HEG), Sponsored by GSK is for all investigators with projects focusing in ovarian cancer and/or related gynecologic cancers research that have a health equity focus as well. Support of $100,000 USD annually for two years will be awarded to the institution in which the recipient will conduct the research.View Health Equity Research Grant, Sponsored by GSK recipients
From 1998 – 2007, OCRF offered Individual Investigator Awards to advance outstanding early career researchers whose projects focused on early detection, screening, and basic translational research. These $100,000 grants were intended to yield results within two years or less. The ultimate aim of the program was to enable investigators, with promising results in hand, to obtain grants from the National Cancer Institute or other large funding agencies.View Individual Investigator Award recipients